Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints Pharmaceutical Investing
Scott+Scott Attorneys at Law LLP Investigates Pfizer, Inc.'s Directors and Officers for Breach of Fiduciary Duties Pharmaceutical Investing
Abbott Launches the First Infant Formula in Canada with an Ingredient Identical in Structure to Immune Component Found in Breast Milk Medical Device Investing
Bristol Myers Squibb Completes Acquisition of MyoKardia, Strengthening Company's Leading Cardiovascular Franchise Biotech Investing
Johnson & Johnson to Address Racial and Social Injustice Through Platform that Aims to Eliminate Health Inequities for People of Color Medical Device Investing
The Bristol Myers Squibb Foundation and National Medical Fellowships Launch $100 Million Program to Help Increase Diversity and Inclusion in Clinical Trials Biotech Investing
Abbott Named Industry Sustainability Leader for the Eighth Year in a Row on the Dow Jones Sustainability Index Medical Device Investing
Lobe Sciences Commences Trading Under New Name and Announces Rebranding and Corporate Update Cannabis Investing News
Algernon Pharmaceuticals Announces Receipt of Refundable Tax Credit from Australian Clinical Research Biotech Investing
